BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35617712)

  • 21. Understanding low colorectal cancer screening uptake in South Asian faith communities in England--a qualitative study.
    Palmer CK; Thomas MC; McGregor LM; von Wagner C; Raine R
    BMC Public Health; 2015 Oct; 15():998. PubMed ID: 26423750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying the factors promoting colorectal cancer screening uptake in Hong Kong using Andersen's behavioural model of health services use.
    Chan DNS; Choi KC; Au DWH; So WKW
    BMC Public Health; 2022 Jun; 22(1):1228. PubMed ID: 35725428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers and Facilitators to Colorectal Cancer Screening in South Asian Immigrants: A Systematic Review.
    Lee J; Ewing B; Holmes D
    Asian Pac J Cancer Prev; 2023 May; 24(5):1463-1475. PubMed ID: 37247265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction to: A family-based multimedia intervention to enhance the uptake of colorectal cancer screening among older south Asian adults in Hong Kong: a study protocol for a cluster randomized controlled trial.
    So WKW; Law BMH; Choi KC; Chan DNS; Chan CWH
    BMC Public Health; 2021 Dec; 21(1):2205. PubMed ID: 34861853
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population.
    Fu WP; Kam MH; Ling WM; Ong SF; Suzannah N; Eu KW
    Tech Coloproctol; 2009 Sep; 13(3):225-30. PubMed ID: 19629380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. South Asian ethnicity, socioeconomic status, and psychological mediators of faecal occult blood colorectal screening participation: A prospective test of a process model.
    Orbell S; Szczepura A; Weller D; Gumber A; Hagger MS
    Health Psychol; 2017 Dec; 36(12):1161-1172. PubMed ID: 28726477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
    Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Community Health Worker-Led Multicomponent Program to Promote Cervical Cancer Screening in South Asian Women: A Cluster RCT.
    Wong CL; Choi KC; Chen J; Law BMH; Chan DNS; So WKW
    Am J Prev Med; 2021 Jul; 61(1):136-145. PubMed ID: 33781617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality improvement intervention to increase colorectal cancer screening at the primary care setting: a cluster-randomised controlled trial.
    Irazola V; Santero M; Sanchez M; Tristao I; Ruiz JI; Spira C; Ismael J; Cavallo AS; Gutierrez L; Mazzaresi Y; Nadal AM; García Elorrio E;
    BMJ Open Qual; 2023 Jun; 12(2):. PubMed ID: 37339820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culturally-adapted behavioral intervention to improve colorectal cancer screening uptake among foreign-born South Asians in New Jersey: the Desi Sehat trial.
    Manne SL; Islam N; Frederick S; Khan U; Gaur S; Khan A
    Ethn Health; 2021 May; 26(4):554-570. PubMed ID: 30394106
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.
    Oyalowo A; Forde KA; Lamanna A; Kochman ML
    JAMA Netw Open; 2022 Mar; 5(3):e224529. PubMed ID: 35357457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
    Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
    BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.
    Smith SG; Wardle J; Atkin W; Raine R; McGregor LM; Vart G; Morris S; Duffy SW; Moss S; Hackshaw A; Halloran S; Kralj-Hans I; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas M; Counsell N; von Wagner C
    BMC Cancer; 2017 Aug; 17(1):543. PubMed ID: 28806955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of hypothetical PErsonalised Risk Information on informed choice and intention to undergo Colorectal Cancer screening colonoscopy in Scotland (PERICCS)-a randomised controlled trial.
    Digby J; O'Carroll RE; Chambers JA; Steele RJC
    BMC Med; 2020 Oct; 18(1):285. PubMed ID: 33076932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.